While downregulation of ST6Gal1 transcription was shown to stimulate tumor cell proliferation both in vitro and in vivo [93], NDAT demonstrated its capability to reduce ST6Gal1 expression and CRC growth. This evidence concerns the gene ST6GAL1 and colorectal carcinoma.